Table 3 Positive potential economic effects for the use of non-invasive monitoring of central pressures

Reduced additional costs for confirmation of white coat hypertension

Avoidance of medication costs for treatment of hypertension when white coat hypertension is present. Reduced costs due to avoidance of medication side effects

Earlier aggressive treatment when there is confirmation of hypertension with associated reduction in socioeconomic costs due to subsequent reduced morbidity

Guidance to attempting trials of medication reduction in treated patients who may have low or low-normal central pressures and normal brachial pressures